vs

Side-by-side financial comparison of Five Point Holdings, LLC (FPH) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $13.6M, roughly 1.6× Five Point Holdings, LLC). Five Point Holdings, LLC runs the higher net margin — -16.4% vs -165.4%, a 149.0% gap on every dollar of revenue. On growth, Five Point Holdings, LLC posted the faster year-over-year revenue change (3.2% vs -25.3%). Over the past eight quarters, NEKTAR THERAPEUTICS's revenue compounded faster (0.4% CAGR vs -48.5%).

Five Point Holdings, LLC is a leading U.S. real estate development company that focuses on planning and constructing large-scale master-planned mixed-use communities in high-demand markets across California. Its projects integrate residential housing, commercial office spaces, retail outlets, public amenities and recreational facilities to build vibrant, sustainable living and working environments for local populations.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

FPH vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.6× larger
NKTR
$21.8M
$13.6M
FPH
Growing faster (revenue YoY)
FPH
FPH
+28.5% gap
FPH
3.2%
-25.3%
NKTR
Higher net margin
FPH
FPH
149.0% more per $
FPH
-16.4%
-165.4%
NKTR
Faster 2-yr revenue CAGR
NKTR
NKTR
Annualised
NKTR
0.4%
-48.5%
FPH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FPH
FPH
NKTR
NKTR
Revenue
$13.6M
$21.8M
Net Profit
$-2.2M
$-36.1M
Gross Margin
Operating Margin
-43.5%
-126.9%
Net Margin
-16.4%
-165.4%
Revenue YoY
3.2%
-25.3%
Net Profit YoY
-109.6%
-596.9%
EPS (diluted)
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FPH
FPH
NKTR
NKTR
Q1 26
$13.6M
Q4 25
$75.9M
$21.8M
Q3 25
$13.5M
$11.8M
Q2 25
$7.5M
$11.2M
Q1 25
$13.2M
$10.5M
Q4 24
$159.8M
$29.2M
Q3 24
$17.0M
$24.1M
Q2 24
$51.2M
$23.5M
Net Profit
FPH
FPH
NKTR
NKTR
Q1 26
$-2.2M
Q4 25
$58.7M
$-36.1M
Q3 25
$21.1M
$-35.5M
Q2 25
$3.3M
$-41.6M
Q1 25
$23.3M
$-50.9M
Q4 24
$121.0M
$7.3M
Q3 24
$4.8M
$-37.1M
Q2 24
$14.7M
$-52.4M
Gross Margin
FPH
FPH
NKTR
NKTR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Operating Margin
FPH
FPH
NKTR
NKTR
Q1 26
-43.5%
Q4 25
89.0%
-126.9%
Q3 25
-268.6%
Q2 25
-324.2%
Q1 25
-425.8%
Q4 24
87.5%
49.2%
Q3 24
83.6%
-142.4%
Q2 24
86.1%
-211.9%
Net Margin
FPH
FPH
NKTR
NKTR
Q1 26
-16.4%
Q4 25
77.3%
-165.4%
Q3 25
156.2%
-301.3%
Q2 25
44.4%
-372.2%
Q1 25
177.0%
-486.4%
Q4 24
75.7%
24.9%
Q3 24
28.0%
-153.6%
Q2 24
28.8%
-222.9%
EPS (diluted)
FPH
FPH
NKTR
NKTR
Q1 26
Q4 25
$-4.67
Q3 25
$-1.87
Q2 25
$-2.95
Q1 25
$-0.24
Q4 24
$-2.07
Q3 24
$-2.66
Q2 24
$-3.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FPH
FPH
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$332.6M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
$89.8M
Total Assets
$3.2B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FPH
FPH
NKTR
NKTR
Q1 26
$332.6M
Q4 25
$425.5M
$15.1M
Q3 25
$351.1M
$41.0M
Q2 25
$456.6M
$43.0M
Q1 25
$528.3M
$38.9M
Q4 24
$430.9M
$44.3M
Q3 24
$224.5M
$30.1M
Q2 24
$217.4M
$27.9M
Stockholders' Equity
FPH
FPH
NKTR
NKTR
Q1 26
$2.3B
Q4 25
$2.3B
$89.8M
Q3 25
$2.3B
$85.1M
Q2 25
$2.2B
$-24.2M
Q1 25
$2.2B
$13.7M
Q4 24
$2.2B
$60.7M
Q3 24
$2.0B
$48.9M
Q2 24
$2.0B
$79.7M
Total Assets
FPH
FPH
NKTR
NKTR
Q1 26
$3.2B
Q4 25
$3.2B
$280.4M
Q3 25
$3.2B
$301.3M
Q2 25
$3.2B
$207.5M
Q1 25
$3.2B
$256.2M
Q4 24
$3.1B
$303.9M
Q3 24
$2.9B
$308.0M
Q2 24
$2.9B
$343.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FPH
FPH
NKTR
NKTR
Operating Cash FlowLast quarter
$-44.5M
$-65.0M
Free Cash FlowOCF − Capex
$-65.0M
FCF MarginFCF / Revenue
-298.0%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FPH
FPH
NKTR
NKTR
Q1 26
$-44.5M
Q4 25
$105.2M
$-65.0M
Q3 25
$40.4M
$-48.8M
Q2 25
$-71.6M
$-45.7M
Q1 25
$56.7M
$-49.1M
Q4 24
$116.0M
$-46.2M
Q3 24
$-18.0M
$-43.9M
Q2 24
$-23.2M
$-37.7M
Free Cash Flow
FPH
FPH
NKTR
NKTR
Q1 26
Q4 25
$105.0M
$-65.0M
Q3 25
$-48.9M
Q2 25
$-71.7M
$-45.8M
Q1 25
$56.7M
$-49.1M
Q4 24
$115.2M
$-46.6M
Q3 24
$-18.2M
$-44.6M
Q2 24
$-23.6M
$-37.9M
FCF Margin
FPH
FPH
NKTR
NKTR
Q1 26
Q4 25
138.4%
-298.0%
Q3 25
-414.5%
Q2 25
-959.3%
-409.6%
Q1 25
430.9%
-469.0%
Q4 24
72.1%
-159.9%
Q3 24
-106.9%
-184.9%
Q2 24
-46.1%
-161.3%
Capex Intensity
FPH
FPH
NKTR
NKTR
Q1 26
0.0%
Q4 25
0.3%
0.1%
Q3 25
0.0%
1.0%
Q2 25
0.8%
0.3%
Q1 25
0.3%
0.0%
Q4 24
0.5%
1.6%
Q3 24
1.3%
2.8%
Q2 24
0.7%
0.8%
Cash Conversion
FPH
FPH
NKTR
NKTR
Q1 26
Q4 25
1.79×
Q3 25
1.92×
Q2 25
-21.58×
Q1 25
2.44×
Q4 24
0.96×
-6.36×
Q3 24
-3.77×
Q2 24
-1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons